Have a personal or library account? Click to login
Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission Cover

Prevalence and factors associated with potential clinically significant drug-drug interactions in patients with cardiovascular diseases at hospital admission

Acta Pharmaceutica
Volume 74 (2024): Issue 4 (December 2024)
By: Iva Marović,  Mario Udovičić,  Diana Rudan,  Šime Manola,  Ivana Samardžić,  Vesna Bačić Vrca,  Maja Ortner Hadžiabdić and  Ivana Marinović  
Open Access
|Jan 2025

Authors

Iva Marović

Department of Clinical Pharmacy, University Hospital Dubrava, Zagreb, Croatia

Mario Udovičić

Clinic of Cardiology University Hospital Dubrava, Zagreb, Croatia

Diana Rudan

Clinic of Cardiology University Hospital Dubrava, Zagreb, Croatia

Šime Manola

Clinic of Cardiology University Hospital Dubrava, Zagreb, Croatia

Ivana Samardžić

Department of Clinical Pharmacy, University Hospital Dubrava, Zagreb, Croatia

Vesna Bačić Vrca

University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Maja Ortner Hadžiabdić

University of Zagreb Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Ivana Marinović

imarinov@kbd.hr

Department of Clinical Pharmacy, University Hospital Dubrava, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2024-0038 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 693 - 708
Accepted on: Nov 18, 2024
Published on: Jan 9, 2025
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
clinical pharmacist,
cardiovascular disease,
drug-drug interactions,
hospital admission
Related subjects:
Pharmacy,
Pharmacy, other

© 2025 Iva Marović, Mario Udovičić, Diana Rudan, Šime Manola, Ivana Samardžić, Vesna Bačić Vrca, Maja Ortner Hadžiabdić, Ivana Marinović, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 74 (2024): Issue 4 (December 2024)Next article